<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="90804">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02023853</url>
  </required_header>
  <id_info>
    <org_study_id>Proed.08.2013.periimplantitis</org_study_id>
    <nct_id>NCT02023853</nct_id>
  </id_info>
  <brief_title>Non Surgical Treatment of Periimplantitis</brief_title>
  <official_title>The Use of Erythritol Powder and Locally Derived Metronidazole for the Non-surgical Treatment of Peri-implant Mucositis and Peri-implantitis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Proed</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Proed</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      20 consecutive adult implant patients, presenting the signs of peri-implant mucositis
      (probing depth ≥4 mm combined with bleeding and/or pus on probing) or  initial
      peri-implantitis (probing depth ≥4 mm, bleeding and suppuration  plus radiographic loss of
      supporting bone ≤30% compared with the situation after implant placement) will be included.

      Sites will be treated by ultrasonic debridement of the pocket, performed using a
      piezoceramic ultrasonic device. For the purpose,  a  Tip will be connected to the
      Handpiece Led (5 minutes/pocket) . Then, it will be followed by the  subgingival use of
      erythritol powder applied by the use of Handpiece  connected to an airflow unit 2x5
      seconds/pocket. At this time the subgingival delivery of metronidazole gel will be provided.
       After instrumentation, patients will rinse with chlorhexidine 0.20% 3 times/day for 2
      weeks.

      At baseline, 1 month, 3 months and 6 months the following parameters will be evaluated:
      Probing Pocket depth (PPD), Bleeding on Probing (BoP), Clinical Attachment Level (CAL).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>probing pocket depth change</measure>
    <time_frame>baseline, 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>bleeding on probing change</measure>
    <time_frame>baseline, 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>clinical attachment level change</measure>
    <time_frame>baseline, 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Peri-Implantitis and Peri-implant Mucositis</condition>
  <arm_group>
    <arm_group_label>ultrasonic, erythritol, metronidazole gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ultrasonic</intervention_name>
    <arm_group_label>ultrasonic, erythritol, metronidazole gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>erythritol</intervention_name>
    <arm_group_label>ultrasonic, erythritol, metronidazole gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>metronidazole gel</intervention_name>
    <arm_group_label>ultrasonic, erythritol, metronidazole gel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients suffering from peri-implant mucositis or peri-implantitis

        Exclusion Criteria:

          -  Heavy smokers current pregnant history of malignancy long-term steroidal or
             antibiotic therapy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniele Cardaropoli, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Proed</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniele Cardaropoli, DDS</last_name>
    <phone>+39.338.6688933</phone>
    <email>dacardar@tin.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>PROED, Institute for Professional Education in Dentistry</name>
      <address>
        <city>Torino</city>
        <zip>10129</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 24, 2013</lastchanged_date>
  <firstreceived_date>December 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Mucositis</mesh_term>
    <mesh_term>Peri-Implantitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Erythritol</mesh_term>
    <mesh_term>Metronidazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
